Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))

Noa Eliakim-Raz; Moran Hellerman; Dafna Yahav; Jonathan Cohen; Ili Margalit; Sharon Fisher; Oren Zusman; Hila Shaked; Jihad Bishara

doi:10.1093/jac/dkx153

Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))

Noa Eliakim-Raz, Moran Hellerman, Dafna Yahav, Jonathan Cohen, Ili Margalit, Sharon Fisher, Oren Zusman, Hila Shaked, Jihad Bishara

Internal Medicine

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

In the fifth paragraph of the Introduction section it says: ‘A recent randomized controlled trial (RCT) conducted in four acute-care hospitals in Israel compared trimethoprim/sulfamethoxazole with vancomycin for the treatment of inpatients with severe MRSA infections. The trial included 252 patients and demonstrated that trimethoprim/sulfamethoxazole was non-inferior compared with vancomycin in the treatment of severe MRSA infections, particularly for patients with bacteraemia.’ The word ‘non-inferior’ should be ‘inferior’.

Original language	English
Pages (from-to)	2687
Number of pages	1
Journal	Journal of Antimicrobial Chemotherapy
Volume	72
Issue number	9
DOIs	https://doi.org/10.1093/jac/dkx153
State	Published - 1 Sep 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dkx153

Cite this

Eliakim-Raz, N., Hellerman, M., Yahav, D., Cohen, J., Margalit, I., Fisher, S., Zusman, O., Shaked, H., & Bishara, J. (2017). Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887)). Journal of Antimicrobial Chemotherapy, 72(9), 2687. https://doi.org/10.1093/jac/dkx153

@article{c6779feaf71b4fc8b9826bb65be34951,

title = "Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))",

abstract = "In the fifth paragraph of the Introduction section it says: {\textquoteleft}A recent randomized controlled trial (RCT) conducted in four acute-care hospitals in Israel compared trimethoprim/sulfamethoxazole with vancomycin for the treatment of inpatients with severe MRSA infections. The trial included 252 patients and demonstrated that trimethoprim/sulfamethoxazole was non-inferior compared with vancomycin in the treatment of severe MRSA infections, particularly for patients with bacteraemia.{\textquoteright} The word {\textquoteleft}non-inferior{\textquoteright} should be {\textquoteleft}inferior{\textquoteright}.",

author = "Noa Eliakim-Raz and Moran Hellerman and Dafna Yahav and Jonathan Cohen and Ili Margalit and Sharon Fisher and Oren Zusman and Hila Shaked and Jihad Bishara",

note = "Publisher Copyright: {\textcopyright} The Author 2017.",

year = "2017",

month = sep,

day = "1",

doi = "10.1093/jac/dkx153",

language = "אנגלית",

volume = "72",

pages = "2687",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "9",

}

Eliakim-Raz, N, Hellerman, M, Yahav, D, Cohen, J, Margalit, I, Fisher, S, Zusman, O, Shaked, H & Bishara, J 2017, 'Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))', Journal of Antimicrobial Chemotherapy, vol. 72, no. 9, pp. 2687. https://doi.org/10.1093/jac/dkx153

Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887)). / Eliakim-Raz, Noa; Hellerman, Moran; Yahav, Dafna et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 72, No. 9, 01.09.2017, p. 2687.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))

AU - Eliakim-Raz, Noa

AU - Hellerman, Moran

AU - Yahav, Dafna

AU - Cohen, Jonathan

AU - Margalit, Ili

AU - Fisher, Sharon

AU - Zusman, Oren

AU - Shaked, Hila

AU - Bishara, Jihad

PY - 2017/9/1

Y1 - 2017/9/1

N2 - In the fifth paragraph of the Introduction section it says: ‘A recent randomized controlled trial (RCT) conducted in four acute-care hospitals in Israel compared trimethoprim/sulfamethoxazole with vancomycin for the treatment of inpatients with severe MRSA infections. The trial included 252 patients and demonstrated that trimethoprim/sulfamethoxazole was non-inferior compared with vancomycin in the treatment of severe MRSA infections, particularly for patients with bacteraemia.’ The word ‘non-inferior’ should be ‘inferior’.

AB - In the fifth paragraph of the Introduction section it says: ‘A recent randomized controlled trial (RCT) conducted in four acute-care hospitals in Israel compared trimethoprim/sulfamethoxazole with vancomycin for the treatment of inpatients with severe MRSA infections. The trial included 252 patients and demonstrated that trimethoprim/sulfamethoxazole was non-inferior compared with vancomycin in the treatment of severe MRSA infections, particularly for patients with bacteraemia.’ The word ‘non-inferior’ should be ‘inferior’.

UR - http://www.scopus.com/inward/record.url?scp=85054383922&partnerID=8YFLogxK

U2 - 10.1093/jac/dkx153

DO - 10.1093/jac/dkx153

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 28510730

AN - SCOPUS:85054383922

SN - 0305-7453

VL - 72

SP - 2687

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 9

ER -

Erratum: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study( J Antimicrob Chemother (2017) 72: (882–887))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this